Objective: To review the methodological quality of systematic review/Meta-analysis(SR/MA) of Shuxuetong in treating stroke. Preferred reporting items for systematic reviews and Meta-analysis(PRISMA) entries and Assessment of Multiple Systematic Reviews(AMSTAR) scale were used to evaluate and analyze the quality of the methodology of the literatures. Method: Chinese Biomedical Literature

China National Knowledge Infrastructure

VIP

Wanfang and PubMed databases were searched to collect literatures for systematic review/Meta-analysis of Shuxuetong in treating stroke. The search time was as at May 2015. Result: Ten articles were included. The average PRISMA score was 22 scores

including one article (10%) with severe deficiency. The AMSTAR scale showed 6 scores on average. The main problems included bias in registered scheme

choice of researches

data extraction and methodology

and no source of fund. Conclusion: The systematic review/Meta analysis for the methodological and report quality of Shuxietong in treating stroke is relatively complete. But it still need to further improve the regimen design

control the quality of prospective literatures

report the sources of fund

and standardize the methodological quality.